| Literature DB >> 33847785 |
Samuel Crompton1, Fabrizio Messina2, Gillian Klafkowski3, Christine Hall4, Amaka C Offiah5,3.
Abstract
BACKGROUND: Recent studies have analysed birth-related clavicular fractures to propose time frames for healing that could be applied to dating of all fractures in cases of suspected child abuse.Entities:
Keywords: Femur; Fracture; Fracture healing; Infant; Radiography; Review
Mesh:
Year: 2021 PMID: 33847785 PMCID: PMC8363550 DOI: 10.1007/s00247-021-05038-3
Source DB: PubMed Journal: Pediatr Radiol ISSN: 0301-0449
Breakdown of radiographs excluded from this study
| No patient notes available | 28 |
| Pathological fracture | 24 |
| Inflicted injury | 17 |
| Date of fracture unidentifiable | 3 |
| Patient with two studies on the same day | 3 |
| No fracture identified | 2 |
| Patient 3 years of age or older | 1 |
Breakdown of the number of radiographs included per patient and patient age
| 5 | 1 | 25 (not applicable) |
| 4 | 3 | 23 (10–23) |
| 3 | 10 | 26 (9–31) |
| 2 | 11 | 23 (3–33) |
| 1 | 5 | 11 (1–24) |
Fig. 1An anteroposterior radiograph of the left femur in an 8-month-old boy shows subperiosteal new bone formation
Fig. 2An anteroposterior radiograph of the left femur in a 15-month-old girl shows callus
Fig. 3A lateral radiograph of the left femur in a 7-month-old girl shows remodelling
Percentage of fractures showing features of fracture healing
| Feature of healing | Age of fracture | % of fractures showing feature (95% confidence interval) | Number of study radiographs |
|---|---|---|---|
| Subperiosteal new bone formation | 0–6 days | 0 (0–0) | 34 |
| 7–11 days | 22.2 (0–49.4) | 9 | |
| 12 days and older | 83.3 (70.0–96.7) | 30 | |
| Callus | 0–14 days | 0 (0–0) | 47 |
| 15–26 days | 50.0 (15.4–84.7) | 8 | |
| 27 days and older | 89.5 (75.7–100) | 19 | |
| Remodelling | 0–22 days | 0 (0–0) | 53 |
| 26–37 days | 26.7 (4.3–49.1) | 15 | |
| 42 days and older | 100 (100–100) | 6 |
Comparison of our data with the findings of Walters et al. [7] for the presence of subperiosteal new bone formation (SPNBF)
| Fracture age | SPNBF present (%) | SPNBF absent (%) | Reader disagreement (%) | |||
|---|---|---|---|---|---|---|
| Walters et al. [ | Present study | Walters et al. [ | Present study | Walters et al. [ | Present study | |
| 0–7 days | 3 | 3 | 92 | 97 | 5 | – |
| 8–9 days | 29 | 20 | 43 | 80 | 28 | – |
| ≥10 days | 98 | 78 | 2 | 22 | – | – |
Comparison of our data with the findings of Walters et al. [7] for the presence of callus
| Fracture age | Callus present (%) | Callus absent (%) | Reader disagreement (%) | |||
|---|---|---|---|---|---|---|
| Walters et al. [ | Present study | Walters et al. [ | Present study | Walters et al. [ | Present study | |
| 0–8 days | 0 | 0 | 100 | 100 | 0 | – |
| 9–14 days | 35 | 0 | 38 | 100 | 27 | – |
| ≥15 days | 98 | 78 | 2 | 22 | 0 | – |
Comparison of our findings with the time line of fracture healing given by Fadell et al. [10]
| Periosteal reaction unlikely <7 days old | 100% (34/34) |
| If periosteal reaction is present alone, likely <11 days old | 25% (2/8) |
| If callus and periosteal reaction are present, likely 11–49 days old | 94% (17/18) |
| If remodelling is present, likely ≥5 weeks | 70% (7/10) |
| Periosteal reaction unlikely beyond 7 weeks | 33% (1/3) |
Reader agreement between the two primary readers for each of the radiographic parameters
| SPNBF | 0.452 | 0.509 | 0.355 |
| Callus | 0.754 | 0.771 | 0.727 |
| Remodelling | 0.527 | 0.553 | – |
– not able to compute due to one reader scoring remodelling as present in zero cases, SPNBF subperiosteal new bone formation
Fig. 4A logistic regression curve for the probability of subperiosteal new bone formation (SPNBF) in patients 12 months and older. The grey boxes correspond to frequency; the lower boxes indicate the frequency of SPNBF not present and the upper boxes indicate the frequency of SPNBF present
Fig. 5An anteroposterior radiograph of the left femur in a 22-month-old boy with the leg in a cast on the date of injury. The superior and medial edge of the cast (arrows) may easily be mistaken for subperiosteal new bone formation